Herbert Pang

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Yingmiao Liu, Jiatong Li, Jing Lyu

|Dec 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).

Andrew B Nixon, Alexander B Sibley, Yingmiao Liu

|Dec 30, 2021
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).

Andrew B Nixon, Susan Halabi, Yingmiao Liu

|Mar 30, 2020
Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer.

Xiaoju Max Ma, Johanna C Bendell, Herbert I Hurwitz

|Jan 11, 2020
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.

Angeles Alvarez Secord, Kirsten Bell Burdett, Kouros Owzar

|Jul 13, 2018
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105.

Yingmiao Liu, Mark D Starr, John C Brady

Pageof 1

Frequent Collaborators

3 joint publications

Alexander B Sibley

3 joint publications

Andrew B Nixon

2 joint publications

Yingmiao Liu

1 joint publications

Kirsten Bell Burdett